Fast Facts: Dermatological Nursing

Fast Facts: Dermatological Nursing
Author :
Publisher : Karger Medical and Scientific Publishers
Total Pages : 152
Release :
ISBN-10 : 9783318071351
ISBN-13 : 3318071358
Rating : 4/5 (51 Downloads)

Book Synopsis Fast Facts: Dermatological Nursing by : Rebecca Penzer-Hick

Download or read book Fast Facts: Dermatological Nursing written by Rebecca Penzer-Hick and published by Karger Medical and Scientific Publishers. This book was released on 2022-10-05 with total page 152 pages. Available in PDF, EPUB and Kindle. Book excerpt:


Fast Facts: Dermatological Nursing Related Books

Fast Facts: Dermatological Nursing
Language: en
Pages: 152
Authors: Rebecca Penzer-Hick
Categories: Medical
Type: BOOK - Published: 2022-10-05 - Publisher: Karger Medical and Scientific Publishers

DOWNLOAD EBOOK

Fast Facts: Managing Immune-Related Adverse Events in Oncology
Language: en
Pages: 142
Authors: Helen Westman
Categories: Medical
Type: BOOK - Published: 2023-04-04 - Publisher: Karger Medical and Scientific Publishers

DOWNLOAD EBOOK

Fast Facts: Managing Immune-Related Adverse Events in Oncology, 2nd edition, provides an overview of immuno-oncology and an update on immune checkpoint inhibito
Fast Facts: Erectile Dysfunction
Language: en
Pages: 92
Authors: Cully Carson
Categories: Medical
Type: BOOK - Published: 2008-06-01 - Publisher: Karger Medical and Scientific Publishers

DOWNLOAD EBOOK

Erectile dysfunction (ED) is a common problem and the source of considerable morbidity, both for individuals and within relationships. With more and more indivi
Fast Facts for the Triage Nurse
Language: en
Pages: 272
Authors: Lynn Sayre Visser
Categories: Medical
Type: BOOK - Published: 2015-05-05 - Publisher: Springer Publishing Company

DOWNLOAD EBOOK

Print+CourseSmart
Fast Facts: Managing immune-related Adverse Events in Oncology
Language: en
Pages: 106
Authors: B.L. Rapoport
Categories: Medical
Type: BOOK - Published: 2021-04-08 - Publisher: Karger Medical and Scientific Publishers

DOWNLOAD EBOOK

Immunotherapeutic products, and immune checkpoints inhibitors in particular, are increasingly used in the management of malignancies, both as monotherapies and